AAAAAA

   
Results: 1-8 |
Results: 8
PARAMETERS FROM LIVER GRAFT PERFUSATES - A VALUABLE TOOL IN THE PREDICTION OF OUTCOME
Authors: SCHENK M ZIPFEL A METZDORF B SAUER U BODE C LAUCHART W VIEBAHN R
Citation: M. Schenk et al., PARAMETERS FROM LIVER GRAFT PERFUSATES - A VALUABLE TOOL IN THE PREDICTION OF OUTCOME, Hepatology, 28(4), 1998, pp. 2302-2302
DATA ON PLACEBO IN HEALTHY-VOLUNTEERS - IMPACT OF EXPERIMENTAL CONDITIONS ON SAFETY, AND ON LABORATORY AND PHYSIOLOGICAL VARIABLES DURING PHASE-I TRIALS
Authors: ROSENZWEIG P BROHIER S ZIPFEL A
Citation: P. Rosenzweig et al., DATA ON PLACEBO IN HEALTHY-VOLUNTEERS - IMPACT OF EXPERIMENTAL CONDITIONS ON SAFETY, AND ON LABORATORY AND PHYSIOLOGICAL VARIABLES DURING PHASE-I TRIALS, Therapie, 51(4), 1996, pp. 356-357
THE PLACEBO-EFFECT IN HEALTHY-VOLUNTEERS - INFLUENCE OF EXPERIMENTAL CONDITIONS ON PHYSIOLOGICAL-PARAMETERS DURING PHASE-I STUDIES
Authors: ROSENZWEIG P BROHIER S ZIPFEL A
Citation: P. Rosenzweig et al., THE PLACEBO-EFFECT IN HEALTHY-VOLUNTEERS - INFLUENCE OF EXPERIMENTAL CONDITIONS ON PHYSIOLOGICAL-PARAMETERS DURING PHASE-I STUDIES, British journal of clinical pharmacology, 39(6), 1995, pp. 657-664
AN EXTENSION OF THE CONTINUAL REASSESSMENT METHODS USING A PRELIMINARY UP-AND-DOWN DESIGN IN A DOSE-FINDING STUDY IN CANCER-PATIENTS, IN ORDER TO INVESTIGATE A GREATER RANGE OF DOSES - DISCUSSION
Authors: ZIPFEL A MOLLER S DURRLEMAN S EZZET F
Citation: A. Zipfel et al., AN EXTENSION OF THE CONTINUAL REASSESSMENT METHODS USING A PRELIMINARY UP-AND-DOWN DESIGN IN A DOSE-FINDING STUDY IN CANCER-PATIENTS, IN ORDER TO INVESTIGATE A GREATER RANGE OF DOSES - DISCUSSION, Statistics in medicine, 14(9-10), 1995, pp. 923-923
ZOLPIDEM AND REBOUND INSOMNIA - A DOUBLE-BLIND, CONTROLLED POLYSOMNOGRAPHIC STUDY IN CHRONIC INSOMNIAC PATIENTS
Authors: MONTI JM ATTALI P MONTI D ZIPFEL A DELAGICLAIS B MORSELLI PL
Citation: Jm. Monti et al., ZOLPIDEM AND REBOUND INSOMNIA - A DOUBLE-BLIND, CONTROLLED POLYSOMNOGRAPHIC STUDY IN CHRONIC INSOMNIAC PATIENTS, Pharmacopsychiatry, 27(4), 1994, pp. 166-175
PLACEBO-EFFECT IN HEALTHY-VOLUNTEERS INFLUENCE OF EXPERIMENTAL CONDITIONS ON PHYSIOLOGICAL-PARAMETERS DURING PHASE 1 STUDIES
Authors: ROSENZWEIG P BROHIER S PINQUIER JL BERGOUGNAN L PALAT A CHAUFOUR S ZIPFEL A
Citation: P. Rosenzweig et al., PLACEBO-EFFECT IN HEALTHY-VOLUNTEERS INFLUENCE OF EXPERIMENTAL CONDITIONS ON PHYSIOLOGICAL-PARAMETERS DURING PHASE 1 STUDIES, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 156-156
LONG-TERM TREATMENT OF BENIGN PROSTATIC HYPERPLASIA WITH ALFUZOSIN - A 24-30-MONTH SURVEY
Authors: JARDIN A BENSADOUN H DELAUCHECAVALLIER MC STALLABOURDILLON A ATTALI P SULHER A TOUBOL J RAMPAL M JURASCHECK F COLOBY P GATTEGNO B ZIPFEL A
Citation: A. Jardin et al., LONG-TERM TREATMENT OF BENIGN PROSTATIC HYPERPLASIA WITH ALFUZOSIN - A 24-30-MONTH SURVEY, British Journal of Urology, 74(5), 1994, pp. 579-584
THE PLACEBO-EFFECT IN HEALTHY-VOLUNTEERS - INFLUENCE OF EXPERIMENTAL CONDITIONS ON THE ADVERSE EVENTS PROFILE DURING PHASE-I STUDIES
Authors: ROSENZWEIG P BROHIER S ZIPFEL A
Citation: P. Rosenzweig et al., THE PLACEBO-EFFECT IN HEALTHY-VOLUNTEERS - INFLUENCE OF EXPERIMENTAL CONDITIONS ON THE ADVERSE EVENTS PROFILE DURING PHASE-I STUDIES, Clinical pharmacology and therapeutics, 54(5), 1993, pp. 578-583
Risultati: 1-8 |